Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00006358
First received: October 4, 2000
Last updated: July 23, 2008
Last verified: October 2006